CTRI/2020/07/026925
Not yet recruiting
Phase 3
Clinical trials to evaluate prophylactic action of Twakadi herbal tea in police professionals working in COVID19 pandemic
Sterling Multispeciality Hosptal and Ayurved Rugnalay0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Sterling Multispeciality Hosptal and Ayurved Rugnalay
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •police professionals working in covid 19 pandemic having age above 25 years irrespective of gender.
- •negative for covid 19\.
- •who are willing to provide signed informed consent
Exclusion Criteria
- •pregnant ladies
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Clinical trial to assess the protective effect of the fixed drug combination of disodium cromoglycate plus reproterol in comparison to the single components and placebo in adults with exercise induced asthma - AERIAExercise induced asthmaMedDRA version: 9.1Level: LLTClassification code 10015649Term: Exercise induced asthmaEUCTR2007-002553-23-DEMEDA Pharma GmbH & Co. KG
Completed
Not Applicable
Clinical trial to evaluate efficacy and safety of low molecular collagen peptides for joint paiKCT0007584Yonsei University Health System, Severance Hospital78
Completed
Phase 3
Clinical trial to evaluate efficacy and safety of KCS03 stent in a native coronary lesioStable angina, unstable angina and non-ST elevated myocardial infarction with de novo or restenotic coronary lesionsJPRN-UMIN000010422Kaneka Corporation115
Completed
Phase 2
Clinical trial to evaluate efficacy and safety of cyclophosphamide, bortezomib and dexamethasone (CBD) induction and autologous stem cell transplantation for patients for newly diagnosed multiple myeloma (NBMT-ASCT1201)multiple myelomaJPRN-UMIN000008399Toyohashi Municipal Hospital Division of Hematology and Oncology54
Completed
Phase 3
Clinical trial to evaluate efficacy and safety of apheresis therapy on peripheral arterial disease with critical limb ischemia.Peripheral arterial diseaseJPRN-UMIN000020336Kaneka Corporation61